Try our Advanced Search for more refined results
Health - August, 2011
243 articles
- Baxter Sues Teva Over Propofol Indemnity Pact
- CareFusion Hits Hospira With Infusion System IP Suit
- FDA Urged To Ban J&J, Allergan Breast Implants
- Merck, Others Can't Dodge Jury's Chromium Verdict
- 2 Classen Patents Pass Bilski Test: Fed. Circ.
- Urology Group Settles Pa.'s Monopoly Claims
- Rejected Individual Deals Don't Doom Classes: 3rd Circ.
- Merck Sues Ky. AG For Using Private Firm In Vioxx Suit
- Medicare Revision Doesn't Bar Contract Suit: Fed. Circ.
- Tainted Avastin Caused Eye Infections: FDA
- Judge Affirms Decision To Allow Coventry Fraud Action
- Acella Loses Bid To Nix False Ad Suit Over Vitamin Labels
- ACA Adaptation: Benefits And Coverage Summaries
- NLRB Reverses Bush-Era Ruling Over Union Challenges
- LabCorp Reaches $49.5M Deal To End Medi-Cal Fraud Suit
- Merck Gets Bellwether Suit Slashed In Fosamax MDL
- Ex-Fed. Circ. Chief, Others Blast Patent Reform
- Bankrupt Drug Tester Can Avoid Inova Lien: 8th Circ.
- Avanir Targets Wockhardt In Nuedexta Patent Blitz
- Ex-Pharma Holdings Execs Shell Out $2M To End Fraud Suit
- Drug Co. Seeks Quick Win On False Ad Claims In IP Suit
- US Should Create Fund For Research Injuries: Report
- Pfizer Settles Lipitor Patent Suit Against Dr. Reddy's
- Bristol-Myers Hit With IP Suit Over Data Encryption
- Hospital Can Bar 'Inflammatory' Pro-Union Gear: Judge
- Shire Patent Suit Over Generic Intuniv Survives
- Mylan Loses Bid To Dismiss MS Drug Patent Suit
- RSUI Drops Appeal In Copyright Suit Coverage Dispute
- Cedars-Sinai Can't Shake Doc's $4.7M Retaliation Award
- 3M Stakes New Forum In BacLite Blackmail Suit
- 11th Circ. Vacates Sanctions Against US In Shaygan Case
- Baxter Workers Win Class Cert. In Meal Break Action
- Group Seeks Faster Label Updates For Generics Makers
- Allergan Sues Sandoz Over Lumigan Patents
- 2011 Attorney Marketing: Where Do You Stand?
- CVS Asks High Court To Put W.Va. Drug Suit In Fed. Court
- Children's Hospital Settles Infant Care Antitrust Suit
- Doc Says Tampa Firm Cut Him Out Of Genzyme Qui Tam
- US, State Pre-Existing Condition Plans See Low Enrollment
- Mylan's Generic Oracea Infringes Galderma IP: Judge
- Amgen Can't Dodge Kickback Claims In Aranesp Suit
- Merck's $32M Damages Nixed In Vioxx Wrongful Death Suit
- Husband Admits He Lied About Ponzi Fugitive's Location
- Argentum To Pay Noble $1M In Fees In Dressing IP Fight
- Pregnant Worker Can't Claim Disability Bias: 7th Circ.
- Nonprofits Escape Calif. Junk Insurance Claims
- Shuttered Drug Co. Recalls Surgical Antiseptics
- Vention Medical Picks Up Tubing Maker Ansamed
- UBS Didn't Earn $7.8M Transaction Fee: Stem Cell Co.
- Alcon Sues Apotex Over Generic Allergy Spray
- 2nd Circ. Nixes Wells Fargo Credit Agreement Row
- Teva Nixes Suit Against Apotex Over Parkinson's Drug
- Hansen Medical Securities Fraud Action Nixed
- Hologic Workers Win Initial Cert. In Overtime Action
- Medtronic Insulin Pumps Open To Cyberattack: Hacker
- Fed. Circ. Upholds Unigene Win Over Fortical Patents
- Foley Snags McDermott M&A Pro For Health Care Group
- UK Seeks Deeper Antitrust Review Of Stericycle Deal
- Balancing The Health Care Reform Debate
- Ex-National Century CEO Takes Convictions To High Court
- Michael Best Adds Polsinelli IP Attys In Chicago
- Kirkland Reps Baxter International In $380M Baxa Buy
- No Government Intervention? No FCA Merit In 5th Circ.
- Class Cert. Granted In Boiron False Advertising Suit
- Mass. Asks To Join Healthpoint Fraud Suit Over Xenaderm
- US Sues To Freeze Assets In Weight Loss Clinic Fraud Case
- A Hindsight-Averse Application Of Lead Compound Case Law
- Sanofi Unit Snaps Up Indian OTC Business For $109M
- Par, UCB Pharma Settle Keppra Patent Fight
- High Doses Of Celexa May Cause Heart Disorder: FDA
- 5th Circ. Gives Stryker Knee Implant Action New Life
- Investor Hits Advanced Cell With $12M Stock Fraud Suit
- CAE Adds Medical Simulator Co. METI For $130M
- Orrick, Arent Rep Par Pharma In $410M Anchen Buy
- Judge Strips Ethypharm's Antitrust Suit Over TriCor IP
- 6th Circ. OKs 7-Year Sentence For NCFE Witness Bribe
- Contractor Settles Civil Suit Over Fake Drug Test Claims
- NY Docs Billed $23M In No-Fault Insurance Fraud: Geico
- GSK Drug Reps Ask High Court To Review OT Exemption
- Fed. Circ. Won't Revive Novartis Hemophilia Drug IP Suit
- Novartis Settles Famvir Patent Dispute
- Beckman Must Boost Lab Device Quality Practices: FDA
- Masimo Targets Philips In Latest Blood Device IP Suit
- Lessons From Stanford
- Judge Says Ventas Can Collect $102M Award From HCP
- Allergan Triumphs In Suits Over Generic Combigan
- Ex-Head Of Drug Testing Co. Cops To Billing Fraud
- St. John's Faces Contract Suit Over Eye Research Deal
- 10 States, DC Defend Health Care Law In 8th Circ.
- Walgreen Nabs Ex-United Air Top Atty
- CDI Seeks Sanctions Against Ex-Employee In FCA Suit
- Troubleshooting ACO Antitrust Enforcement
- Cravath Reps Aptuit In $410M Deal With Catalent
- CVS Agrees To Pay $2M Over Misleading Pricing Ads
- Masimo Hit With Oximetry Device IP Suit
- FTC Loses Lundbeck Baby Meds Fight Before 8th Circ.
- Cadence Sues Exela, Paddock To Block Generic Ofirmev
- Blackstone, Goldman Escape Junk Insurance Case
- State Quota Violates Commerce Clause, Not Sherman Act
- Novartis, Apotex Resolve Suit Over Myfortic Patents
- Schering Says Judge Missed Key Facts In Sales Rep OT Suit
- Damages Only — No 'Full Billed Charges' Allowed
- Class Status Sought In Express Scripts-Medco Deal Suit
- Blank Rome Scores IP Pro From Vorys
- Overhauling The 510(k) Process
- Smith & Nephew Hit With Knee Implant Patent Suit
- Ex-Lab Owner Admits To Selling Unapproved Stem Cells
- KVK Accuses Sunrise Of Stealing Employees, Trade Secrets
- Sandoz Wants Novo's Prandin Patent Ruled Invalid Again
- Allergan Sues Again To Block Generic Latisse
- Judge OKs Medical Monitoring For DuPont Plaintiffs
- Personal Injury Plaintiffs Can't Recoup Fee Discounts: Court
- Forest Labs Defeats Icahn In Proxy Fight
- Laying Claim To DNA
- 2nd Circ. Rejects NYC Bid To Undo Insurance Merger
- Jury Hands Win To Breg In 1st Pain Pump Trial
- Endo Strikes Mylan With Suit Over Generic Frova
- HHS Unveils Standardized Health Insurance Forms
- Insurers Correctly Defined Cancer Coverage: Judge
- Panel Backs Most Allegra Ad Claims
- Pfizer Sues To Block Generic Lipitor
- NM Hospital Seeks Ch. 11 As Malpractice Suits Loom
- P&G Denture Cream Suits To Stay Put In MDL
- Pa. Hospital Group Sued Over Meal Break Policy
- Darvocet, Darvon Heart Risk Suits Consolidated
- Baxter Says Fresenius Owes $20M Over Dialysis Patent
- Medicis, Nycomed Settle Vanos Patent Dispute
- Google, Others Back Fed. Circ. Joint Infringement Rulings
- Abbott Targets Teva Over Latest Simcor ANDA
- Personalized Medicine, Patents And The Supreme Court
- Implications Of Blanco V. Bath Iron Works
- Abbott Hit With 2 Suits Over Depakote Birth Defects
- Indirect Purchasers Certified In Wellbutrin Antitrust Suit
- Judge Boots Investor Class Action Over Feraheme Risks
- Pfizer Sues Merck, Schering Unit Over Lipitor Look-Alike
- FDA Unveils New Standards For Premarket Device Studies
- Investors Target BioMimetic Over Bone Graft Statements
- Class Certified In Cigna Autism Treatment Suit
- Pfizer's Viagra Patent Survives Teva Challenge
- Applying Section 1 To Hospital Peer Review Decisions
- Dentists Win Class Cert. In Nobel Biocare Implant Suit
- Sanofi Says Sales Rep OT Suit Exploits FLSA Loophole
- Ex-FrontPoint Trader Cops To Receiving Insider Tips
- Ex-MediSys CEO Made Up Lawmakers' Consulting Gigs: US
- Anti-Health Care Reform Measure To Be On Ohio Ballot
- Fed. Circ. Denies Eon's Fee Bid In Skelaxin IP Case
- CDI Gets Stark Act Claim Tossed In Medicare FCA Suit
- Body Science Aims To Ax Winston & Strawn From IP Case
- 9th Circ. Affirms Dismissal Of Health Care Law Suit
- Health Law's Mandate Unconstitutional: 11th Circ.
- 6th Circ. Nixes Class Cert. In Blue Cross ERISA Suit
- Stryker Unit Dodges Zimmer's Sanctions Bid
- Funding Regional Insurance Programs
- AstraZeneca Settles Idaho's AWP Suit For $2.5M
- St. Vincent's $34M Sale Of Nursing Home OK'd
- FLSA Cert. Process Challenged In Light Of Dukes
- Insurance Overpayment Suit Belongs In State Court: Judge
- GSK Wins False Patent Marking Suit Over Citrucel
- Avanir Sues Par, Actavis To Block Generic Nuedexta
- Inside Sorrell V. IMS Health
- Legal Implications Of New Cancer Causation Theories
- Ex-FrontPoint Trader Ends $30M SEC Insider Trading Suit
- EFF Asks Fed. Circ. To Deny Akamai, McKesson IP Claims
- Bayer, Lilly False Ad Row Over Pet Meds To Stay In NY
- Elan Beats Investor Fraud Claims Over Drug Prospects
- Vioxx Judge Reallocates $315M Counsel Award
- 7th Circ. Nixes CUNA Sick Leave Action
- The Skinny On Texas Senate Bill 7
- Lilly, Hospira Settle Gemzar Patent Fight
- S&N Relator Seeks Sales Docs For Non-US Goods
- Pfizer Can't Shake Investor Suit Over Off-Label Marketing
- EU Patent Decision Admissible In Yaz Row, Bayer Says
- J&J Cuts Deal With US Over Risperdal Marketing Fraud
- Italy Hits Toshiba Unit, Others With €5.5M Antitrust Fine
- JPMorgan Let Health Facility Boss Steal $2M, Suit Claims
- Cooley Snags 3 Life Sciences Partners From Seed IP
- Insurers' Rescission Claim Survives In Heparin Suit
- Caliper, Carestream Settle Animal Imaging IP Row
- Wyeth, Sandoz Lay Down Swords In Effexor Patent Row
- Most Claims Stand In Securities Suit Over Vioxx Risks
- Zimmer Knee Implant Actions Merged Into MDL
- Abbott Fights $3.5M Verdict In GSK Suit Over Norvir
- Forest Decision Does Little To Remove Exclusion Threat
- Canadian Class Certified In Suit Over Wyeth's Premarin
- US Probes Merck's Marketing Of 3 Drugs
- HHS Wants Input On Metadata Standards
- Teva Sued Over Generic HIV Drug
- Clinic's Unsupervised Heart Tests Violated FCA: Suit
- FTC Says NY Pharmacy Choice Bill Could Curb Competition
- Emdeon Investor Fights $3B Blackstone Buyout
- Pozen Wins Injunction On Generic Treximet
- Ex-Schering Sales Reps Prevail In FLSA Suit
- Hogan Lovells Snags Ex-Medtronic Atty With FDA Chops
- 1st Circ. Tosses Boston Scientific Securities Fraud Action
- Brigham And Women's Hospital Says It Lost Patient Info
- 5th Circ. Nixes Relator From McKesson Kickbacks Case
- Ill. Agency Can't Nix Health Plan Contract Freeze
- US Ends Bid To Oust Forest Labs CEO Solomon
- Canada Links Merck Drugs To Male Breast Cancer
- Health Care Competition: Beware The Middleman
- Ex-Orioles Player Settles Insider Trading Suit For $2.5M
- Ferring, Aventis Reach $20M Deal In DDAVP Antitrust Suit
- Ropes & Gray Reps Blackstone In $3B Emdeon Buyout
- Mayer Brown Reps DeVry In $235M Medical School Deal
- Illumina Asks Fed. Circ. To Revive Affymetrix IP Suit
- AstraZeneca Targets Hetero Over Nexium ANDA
- Surviving The 'Magic Microscope' Test
- Hospital Group Blasts HHS' Call For Access Reports
- Allied Shareholder Tries To Halt $175M Saga Deal
- Forest Labs Told To Turn Over Docs On CEO To Icahn
- 3rd Circ. Nixes Doctors' Challenge To Health Care Law
- Prescription Confidentiality Law And The Privacy Debate
- Baker Donelson Adds Ex-Bayer CropScience Patent Head
- High-Dose Diflucan May Cause Birth Defects: FDA
- Dozens Of Health Insurers Sued Over Settlement Liens
- Watchdog Attacks FDA Over Expert Conflicts Policy
- 8th Circ. Revives KV Antifungal Cream Trade Secrets Row
- 10th Circ. Revives Prozac Murder-Suicide Suit
- KemPharm Exec Can't Dodge Shire's Contract Claims
- Omnicom Courts Big Pharma With Synergy Deal
- WebMD Accused Of Hiding Ad Woes Before Stock Plunge
- Detecting Waste And Abuse In Health Care Spending
- Chinese Reverse Merger Co. Hyped 'Worthless' Stock: Suit
- Takeda Accused Of Hiding Diabetes Drug's Cancer Link
- Judge Trims Boehringer Sales Reps' OT Class Action
- Health Plan Cos. Take $2.4M Hit In Marketing Fraud Case
- 8th Circ. Denies 3rd Look At Catheter Antitrust Suit
- US Oncology Debtholders Seek $40M From McKesson Tie-Up
- Feds Fail To Keep FCA Docs Sealed In Omnicare Case
- Immunosyn Execs Hit With $20M Insider Trading Suit
- Fed. Circ. Sides With GSK, Others In Argatroban IP Row
- Gilead Tries To Nix Whistleblower's Retaliation Suit
- US Says States Should Have Final Say On Insurance Rates
- Cantel Expands GI Capabilities With $100M Byrne Deal
- FMC To Shell Out $2.1B For Dialysis Cos.
- Pfizer Unit Wants $65M More For Asbestos Ch. 11
- Hospital Wants More In $3.5M Sex Abuse Coverage Suit
- Mass. Sues J&J Unit Over Risperdal Off-Label Marketing
- Horvitz & Levy Sued Over Missed Deadline In Firing Suit
- Suit Says Zynex Directors' Deception Inflated Stock
- Pharmacies Fight $29B Express Scripts, Medco Deal
- Insurers Must Cover Birth Control At No Cost: HHS
- Is The Medical Device Review System Flawed?